XML 68 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
12 Months Ended
Dec. 28, 2019
USD ($)
Dec. 29, 2018
USD ($)
Dec. 30, 2017
USD ($)
Cash flows from operating activities:      
Net income (loss) $ 43,493 $ (26,322) $ (70,562)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 33,056 39,261 57,861
Impairment of acquired intangible assets 0 12,486 32,431
Stock-based compensation expense 18,899 13,646 12,543
Reduction in the carrying amount of right-of-use assets 5,797 0 0
Loss on re-financing of long-term debt 2,235 0 0
Amortization of debt issuance costs and discount 1,659 2,230 1,982
Impairment of operating lease right-of-use asset (recorded in Restructuring charges) 977    
Impairment of operating lease right-of-use asset (recorded in Restructuring charges) 4,664 17,349 7,196
Gain on sale of building 0 0 (4,624)
Loss on sale of assets and business units 0 0 1,496
Other non-cash adjustments (374) (79) 1,707
Changes in assets and liabilities:      
Accounts receivable, net (4,027) (3,978) 44,613
Inventories 12,116 13,177 (902)
Prepaid expenses and other assets 3,740 (11,667) 889
Accounts payable and accrued expenses (includes restructuring) 9,261 13,325 (23,588)
Accrued payroll obligations 4,039 (1,051) 726
Operating lease liabilities, current and long-term portions (6,896)    
Income taxes payable 162 498 (556)
Deferred income and allowances on sales to distributors   0  
Net cash provided by operating activities 124,137 51,458 38,514
Cash flows from investing activities:      
Proceeds from sales of and maturities of short-term marketable securities 9,655 5,000 12,689
Purchases of marketable securities 0 (9,603) (7,420)
Proceeds from sale of building 0 0 7,895
Cash paid for costs of sale of building 0 0 (1,004)
Capital expenditures (15,590) (8,384) (12,855)
Proceeds from sale of assets and business units, net of cash sold 0 0 967
Repayment received on short-term loan to cost-method investee 0 0 2,000
Short-term loan to cost-method investee 0 0 (2,000)
Cash paid for software licenses (9,601) (8,123) (8,532)
Net cash used in investing activities (15,536) (21,110) (8,260)
Cash flows from financing activities:      
Restricted stock unit tax withholdings (10,084) (2,370) (3,267)
Proceeds from issuance of common stock 17,166 29,288 6,085
Proceeds from issuance of long-term debt 206,500 0 0
Original issue discount and debt issuance costs (2,086) 0 0
Repayment of debt (321,408) (43,759) (35,429)
Net cash used in financing activities (109,912) (16,841) (32,611)
Effect of exchange rate change on cash 341 (1,271) 2,620
Net (decrease) increase in cash and cash equivalents (970) 12,236 263
Beginning cash and cash equivalents 119,051 106,815 106,552
Ending cash and cash equivalents 118,081 119,051 106,815
Supplemental disclosure of cash flow information and non-cash investing and financing activities:      
Interest paid 10,995 18,607 20,649
Operating lease payments 8,425    
Income taxes paid, net of refunds 3,393 3,054 2,387
Accrued purchases of property and equipment 826 110 588
Operating lease right-of-use assets obtained in exchange for lease obligations 747    
Note receivable resulting from sale of assets and business units 0 0 3,050
Product      
Changes in assets and liabilities:      
Deferred income and allowances on sales to distributors 0 0 (15,007)
Licensing and services      
Changes in assets and liabilities:      
Deferred income and allowances on sales to distributors $ 0 $ (68) $ (495)